Bode-Lesniewska Beata
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
Acta Cytol. 2016;60(4):354-364. doi: 10.1159/000448325. Epub 2016 Aug 30.
Cytopathologists are regularly confronted with lymphocyte-rich effusions, and the definite decision of whether the lymphocytosis is of a purely reactive nature or a presentation of an indolent lymphoma may be an extremely difficult one based on microscopy alone. Flow cytometry (FC) offers many advantages in terms of its application in body cavity fluids, and it has proven to be very useful both in the setting of a known disease and for new lymphoma diagnoses. In this paper, the studies published in recent years dealing with the applications of FC in body cavity effusions in the context of hematologic neoplasia are reviewed, stressing the integrative diagnostic approach. The incorporation of microscopical, immunophenotypical, and molecular findings from examinations of the cellular content of effusions and the interpretation of results in relation to the current WHO classification of hematolymphoid malignancies give cytopathologists new perspectives on advanced and clinically highly relevant diagnostics.
细胞病理学家经常会遇到富含淋巴细胞的积液,仅基于显微镜检查来明确判断淋巴细胞增多是纯粹的反应性还是惰性淋巴瘤的表现可能极其困难。流式细胞术(FC)在体腔液中的应用具有诸多优势,并且已证明在已知疾病的情况下以及新淋巴瘤的诊断中都非常有用。本文回顾了近年来发表的关于FC在血液系统肿瘤背景下体腔积液应用的研究,强调综合诊断方法。将积液细胞成分检查的显微镜、免疫表型和分子结果与当前世界卫生组织血液淋巴系统恶性肿瘤分类相结合,为细胞病理学家提供了关于先进且临床高度相关诊断的新视角。